What is the share price of Trident Clinical Research India Pvt. Ltd. (Amalgamated)?

Company share prices are keep on changing according to the market conditions. The current trading price of Trident Clinical Research India Pvt. Ltd. (Amalgamated) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Trident Clinical Research India Pvt. . (Amalgamated)?

The latest standalone P/E ratio of Trident Clinical Research India Pvt. . (Amalgamated) as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Trident Clinical Research India Pvt. Ltd. (Amalgamated)?

The latest standalone P/B ratio of Trident Clinical Research India Pvt. Ltd. (Amalgamated) as of 01-Jan-1970 is 0.00.

What is the 52-week high and low of Trident Clinical Research India Pvt. Ltd. (Amalgamated)?

The 52-week high of Trident Clinical Research India Pvt. Ltd. (Amalgamated) is Rs. and the 52-week low is Rs. .

Trident Clinical Research India Pvt. Ltd. (Amalgamated) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Trident Clinical Research India Pvt. Ltd. (Amalgamated)
Brand: Trident Clinical Research India Pvt. . (Amalgamated)

Trident Clinical Research India Pvt. Ltd. (Amalgamated)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Pharmaceuticals & Drugs | Small Cap | Trident Clinical Share Price

Trident Clinical Research India Pvt. Ltd. (Amalgamated)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Pharmaceuticals & Drugs | Small Cap | Trident Clinical Share Price

Key Metrics

Valuation Multiples

Market Cap

₹0 Cr.

Current Price

₹0

52-Week Low / High

₹0 / 0

TTM EPS

₹0

TTM Sales

₹1.6 Cr.

Book Value per Share

P/E Ratio

0.00

Industry PE

49.8

Price to Book (P/B)

0.00

Price to Sales (P/S)

0.00

EV/EBITDA

0.00

Dividend Yield

NAN%

Profitability Efficiency

Return on Equity (ROE)

8.09%

Return on Capital Employed (ROCE)

12.44%

Return on Assets (ROA)

7.72%

Operating Profit Margin

28.7%

Net Profit Margin

12.26%

Gross Profit Margin

27.4%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Improving versus 3-year growth rate

-8.57%

Operating Profit Growth (1 Year)

Improving versus 3-year growth rate

13.16%

Net Profit Growth (1 Year)

Improving versus 3-year growth rate

42.86%

Asset Quality

Promoter Holding

Pledged shares (%) of Promoter's holding (%)

Reserves

₹2 Cr.

Equity

₹0 Cr.

Face Value

₹10

All Time Low / High

- / -

Trident Clinical Research India Pvt. . (Amalgamated) stock performance

Key Ratios

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	TTM
ROCE % ⓘ	16%	14.2%	22.7%	52%	11.8%	10.4%	12.4%	-
Growth Parameters ⓘ
Sales ⓘ	1.4	1.7	2	2.8	1.8	1.8	1.6	2
Sales YoY Gr.	-	20.4%	15.8%	40.9%	-37.3%	0%	-8.6%	-
Adj EPS ⓘ	18.9	21.4	27.6	86.5	23.9	21.7	29.5	0
YoY Gr.	-	13%	29.1%	213.7%	-72.3%	-9.4%	36.1%	-
BVPS (₹) ⓘ	139.4	161	192.1	278.6	302	322.1	349.2	0
Adj Net Profit ⓘ	0.2	0.2	0.2	0.6	0.2	0.2	0.2	0
Cash Flow from Ops. ⓘ	0	0	0	0	0	0.5	0.3	-
Debt/CF from Ops. ⓘ	0	0	0	0	0	0	0	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	-1.3%	-16.9%	-8.6%
Adj EPS ⓘ	NA	6.7%	-30.1%	36.1%
BVPSⓘ	NA	16.7%	7.8%	8.4%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	TTM
Return on Equity % ⓘ	13.5	14.2	14.2	36.8	8.2	7	8.8	0
Op. Profit Mgn % ⓘ	20.8	12.7	19.4	40.4	23.3	22.5	28.7	NAN
Net Profit Mgn % ⓘ	11.7	11	10.1	22.4	9.9	8.9	13.3	0
Debt to Equity ⓘ	0	0	0	0	0	0	0	-
Working Cap Days ⓘ	0	93	120	172	299	219	227	0
Cash Conv. Cycle ⓘ	0	-38	-347	-609	-813	144	145	0

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15
Sales	1.42	1.71	1.98	2.79	1.75	1.75	1.60
Operating Expenses ⓘ +	1.16	1.50	1.60	1.66	1.34	1.37	1.16
Manufacturing Costs	0.01	0	0	0	0	0.06	0.06
Material Costs	0	0	0	0	0	0	0
Employee Cost	0.48	0	0	0	0	0.52	0.32
Other Costs ⓘ	0.67	1.50	1.60	1.66	1.34	0.80	0.79
Operating Profit ⓘ	0.26	0.22	0.38	1.13	0.41	0.38	0.43
Operating Profit Margin (%)	18.6%	12.7%	19.3%	40.4%	23.3%	21.5%	27.2%
Other Income ⓘ +	0	0	0	0	0	0	0.01
Exceptional Items ⓘ	0	0	0	0	-0	0	0
Interest ⓘ	0	0	0	0	0	0	0
Depreciation ⓘ	0.07	0.03	0.07	0.24	0.15	0.14	0.14
Profit Before Tax ⓘ	0.20	0.19	0.32	0.88	0.25	0.23	0.30
Tax ⓘ	0.05	0	0.12	0.26	0.08	0.09	0.10
Profit After Tax	0.14	0.19	0.20	0.62	0.17	0.14	0.20
PAT Margin (%)	10.2%	11.0%	10.1%	22.4%	9.7%	8.3%	12.3%
Adjusted EPS (₹)	16.4	21.4	27.6	86.5	23.5	20.0	27.2
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%

Valuation of Trident Clinical - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15
Equity and Liabilities
Shareholders Fund +	1.23	1.42	1.39	2.01	2.18	2.32	2.52
Share Capital ⓘ	0.09	0.09	0.07	0.07	0.07	0.07	0.07
Reserves ⓘ	1.15	1.33	1.31	1.94	2.11	2.25	2.45
Debt +	0	0	0	0	0	0	0
Long Term Debt	0	0	0	0	0	0	0
Short Term Debt	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0
Trade Payables	0	0.02	0.14	0.83	0.04	0.03	0.02
Others Liabilities ⓘ	0.19	0.39	0.34	0.44	0.07	0.04	0.13
Total Liabilities ⓘ	1.43	1.83	1.87	3.29	2.29	2.40	2.68
Fixed Assets
Net Fixed Assets ⓘ +	0.09	0.08	0.42	0.66	0.68	0.61	0.58
Gross Block	0.23	0.26	0.57	0.90	1.01	1.08	1.18
Accumulated Depreciation	0.14	0.17	0.15	0.24	0.33	0.47	0.61
CWIP ⓘ	0	0	0	0	0	0	0
Investments ⓘ	0	0	0	0	0	0	0
Inventories	0	0	0	0	0	0	0
Trade Receivables	0.47	0.31	0.68	1.20	0.89	0.67	0.78
Cash Equivalents ⓘ	0.83	1.37	0.52	0.92	0.45	0.86	1.05
Others Assets ⓘ	0.04	0.06	0.25	0.50	0.28	0.27	0.28
Total Assets ⓘ	1.43	1.83	1.87	3.29	2.29	2.40	2.68

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'14	Mar'15
Cash Flow From Operating Activity ⓘ +	0.48	0.29
PBT ⓘ	0.23	0.31
Adjustment ⓘ	0.14	0.18
Changes in Working Capital ⓘ	0.19	-0.07
Tax Paid ⓘ	-0.09	-0.11
Cash Flow From Investing Activity ⓘ +	-0.07	-0.10
Capex	-0.07	-0.11
Net Investments	0	0
Others ⓘ	0	0
Cash Flow From Financing Activity ⓘ +	-0	0
Net Proceeds from Shares ⓘ	0	0
Net Proceeds from Borrowing ⓘ	0	0
Interest Paid ⓘ	-0	-0
Dividend Paid ⓘ	0	0
Others ⓘ	0	0
Net Cash Flow ⓘ	0.41	0.19

Financial Ratio

PARTICULARS	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15
Ratios
ROE (%)	11.77	14.22	14.18	36.75	8.09	6.42	8.09
ROCE (%)	16.02	14.22	22.65	51.99	11.82	10.44	12.44
Asset Turnover Ratio	1	1.05	1.07	1.08	0.63	0.75	0.63
PAT to CFO Conversion(x)	0	2.53	1.45	0	0	0	0
Working Capital Days
Receivable Days	119.70	83.10	91.90	123.30	217.50	161.90	165
Inventory Days	0	0	0	0	0	0	0
Payable Days	0	0	0	0	0	0	0

Management X-Ray

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Trident Clinical Research India Pvt. Ltd. (Amalgamated) FAQs

The current trading price of Trident Clinical on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Trident Clinical stood at ₹0.00 Cr

The latest P/E ratio of Trident Clinical as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Trident Clinical as of 31-Dec-1969 is 0.00.

The 52-week high of Trident Clinical is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Trident Clinical is ₹1.60 ( Cr.) .

Data is not available for this company.

No data found

About Trident Clinical Research India Pvt. Ltd. (Amalgamated)

No data to display

Trident Clinical Research India Pvt. Ltd. (Amalgamated)

Trident Clinical Research India Pvt. Ltd. (Amalgamated)

Trident Clinical Research India Pvt. . (Amalgamated) stock performance

10 Year X-Ray :